<h2 class="mt-4 text-lg font-medium text-color-lightgreytext" data-astro-cid-fjd3bvuv>
Summary from the AllSides News Team
</h2> <div class="mt-2 text-md editor-content" data-astro-cid-fjd3bvuv><p>On Wednesday, the Food and Drug Administration authorized <a href="/story/pfizer-allow-generic-drugmakers-manufacture-covid-19-antiviral-pill">Pfizer’s antiviral pill</a> to treat mild-to-moderate COVID-19.&nbsp;</p>

<p>The pill, Paxlovid, is the first authorized at-home prescription treatment for the disease. The <a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19" target="_blank" rel="noopener noreferrer">authorization</a> is limited to patients 12 and older who test positive and&nbsp;“are at <a href="/news/2021-11-05-0643/covid-pfizer-says-antiviral-pill-89-effective-high-risk-cases">high risk</a> for progression to severe COVID-19.” “This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research.&nbsp;</p>

<p>Coverage was widespread and featured prominently across the spectrum. Coverage was mostly balanced on all sides, with some outlets calling the pill “highly anticipated” or&nbsp;a “long-awaited milestone.”</p>
</div> <h2 class="mb-2 leading-6 text-lg text-gray-500 font-medium mt-4 p-0">
Featured Coverage of this Story
</h2> <div class="flex gap-5 my-2 mb-8 md:flex-row flex-col"> <div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--fda-authorizes-first-covid-pill-from-pfizer-for-emergency-use" href="https://www.nbcnews.com/health/health-news/fda-authorizes-first-covid-pill-pfizer-emergency-use-rcna8760" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">FDA authorizes first Covid pill, from Pfizer, for emergency use</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">NBC News Digital</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/211116-pfizer-Paxlovid-al-1133-625c11.jpg" alt="FDA authorizes first Covid pill, from Pfizer, for emergency use" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Pfizer</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>The Food and Drug Administration on Wednesday authorized the first Covid-19 antiviral pill in the United States to protect against severe disease.</p><p>The oral drug, called Paxlovid, from Pfizer will be prescribed for use in adults and children ages 12 and up with mild to moderate Covid who are at risk for severe disease or hospitalization, the FDA said in a statement.</p><p>The authorization marks "a major step forward" in the pandemic, Dr. Patrizia Cavazzoni, director of the agency’s Center for Drug Evaluation and Research, said in a statement.</p><p>“This...</div><a id="Open-On--nbc-news-digital" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.nbcnews.com/health/health-news/fda-authorizes-first-covid-pill-pfizer-emergency-use-rcna8760" target="_blank" rel="noopener">
Open on NBC News Digital<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><script type="5229e0e9583992b0e732523a-module" src="/_astro/story-related-news.astro_astro_type_script_index_0_lang.DjPUAy8u.js"></script><div class="flex-1 left"><div class="mb-2 font-bold border-solid global-bias-label text-color-left border-b-[3px] text-s border-color-left">From the Left</div><a id="News-Item--fda-authorizes-pfizer-covid-antiviral-pill-for-high-risk-individuals" href="https://www.axios.com/fda-pfizer-covid-antiviral-pill-paxlovid-authorization-274ee4ed-3b4e-49c1-afbf-b5861dc2ef2c.html" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">FDA authorizes Pfizer COVID antiviral pill for high-risk individuals</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Axios</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-left.png" alt="AllSides Media Bias Rating: Lean Left" title="AllSides Media Bias Rating: Lean Left" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/1640118156101.jpg" alt="FDA authorizes Pfizer COVID antiviral pill for high-risk individuals" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Photo courtesy of Pfizer Inc.</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>The Food and Drug Administration on Wednesday&nbsp;authorized&nbsp;Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19.</p><p>Why it matters:&nbsp;At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible game-changers for the pandemic. The emergency use authorization comes as the U.S. sees a&nbsp;surge&nbsp;in new COVID-19 cases and hospitalizations largely driven by the Omicron variant.</p><p>Driving the news:&nbsp;Pfizer&nbsp;released new data&nbsp;last week confirming Paxlovid reduced the risk of hospitalization or death by 89% in high-risk adults, Axios' Tina Reed&nbsp;reports.</p><p>An interim analysis of a second study of...</div><a id="Open-On--axios" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.axios.com/fda-pfizer-covid-antiviral-pill-paxlovid-authorization-274ee4ed-3b4e-49c1-afbf-b5861dc2ef2c.html" target="_blank" rel="noopener">
Open on Axios<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div><div class="flex-1 right"><div class="mb-2 font-bold border-solid global-bias-label text-color-right border-b-[3px] text-s border-color-right">From the Right</div><a id="News-Item--fda-authorizes-first-covid-19-treatment-pill-pfizer-s-paxlovin-drug" href="https://www.foxbusiness.com/markets/fda-authorizes-pfizer-oral-antiviral-covid-19-treatment" target="_blank" rel="noopener"><div class="m-0 font-bold leading-tight text-md hover:underline text-base">FDA authorizes first COVID-19 treatment pill, Pfizer&#39;s Paxlovin drug</div></a><div class="flex gap-2 items-center pt-2 hover:underline"><div class="overflow-hidden whitespace-nowrap"><p class="text-xs">Fox Business</p></div><img src="https://img.allsides.com/sites/default/files/bias-leaning-right.png" alt="AllSides Media Bias Rating: Lean Right" title="AllSides Media Bias Rating: Lean Right" width="72" height="12" class="news-source-bias-image shrink-0" style="width: 72px !important; height: 12px !important; max-width: 72px !important;"><div class="flex-1 text-right ml-2 text-xs text-gray-500 underline whitespace-nowrap">
See rating details
</div></div><div class="mt-4"><div class="relative w-full"><img src="https://img.allsides.com/sites/default/files/2021-11-16T211909Z_282971589_RC29AQ9E56SE_RTRMADP_3_HEALTH-CORONAVIRUS-USA-PFIZER.jpg" alt="FDA authorizes first COVID-19 treatment pill, Pfizer's Paxlovin drug" class="w-full h-auto object-cover"><div class="absolute bottom-0 left-0 right-0 h-12 bg-gradient-to-b from-color-transparent via-color-black/70 to-color-black px-1 pb-0 text-color-white flex items-end"><p class="text-xs pb-0.5">Pfizer/Handout via REUTERS (Reuters)</p></div></div></div><div class="mt-4"><div class="block text-xs leading-none mb-1 text-color-lightgreytext uppercase align-middle">News</div><div class="[&>p]:my-2 text-sm editor-content"><p>The&nbsp;Food and Drug Administration&nbsp;authorized the first oral antiviral treatment for COVID-19, Pfizer's Paxlovid drug.</p><p>Emergency use authorization was granted Wednesday for Pfizer's Paxlovid – nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use – for the treatment of mild-to-moderate coronavirus disease in adults and children 12 years of age or older weighing at least 40 kilograms or about 88 pounds.&nbsp;</p><p>It applies only to those who meet those qualifications, have tested positive for SARS-CoV-2 testing and "who are at high risk for progression to severe COVID-19, including hospitalization or death,"...</div><a id="Open-On--fox-business" class="text-xs inline-block border-b border-color-transparent no-underline font-bold whitespace-nowrap" href="https://www.foxbusiness.com/markets/fda-authorizes-pfizer-oral-antiviral-covid-19-treatment" target="_blank" rel="noopener">
Open on Fox Business<i class="fa-regular fa-arrow-up-right-from-square ml-2"></i></a></div></div> </div> <p class="mt-2 mb-5 text-right"> <a id="More-headline-roundups" class="group relative pr-5 hover:no-underline border-b border-opacity-0 hover:border-opacity-100 border-color-text inline-block w-fit cursor-pointer text-sm no-underline" href="/headline-roundups">